Studies on Some Cytokines, CD4, Hepcidin, Iron, and Some Haematological Parameters of Patients with Pulmonary Tuberculosis and Human Immunodeficiency Virus in Southeast, Nigeria
Journal of Pharmaceutical Research International,
The research was done to evaluate the levels of IFN-γ, IL-6, IL- 10, iron status, hepcidin and haematological parameters of patients with pulmonary tuberculosis and human immunodeficiency virus in a tertiary hospital, Southeast, Nigeria. Four hundred (400) subjects aged 18-60 years were selected for this study. The participants comprised of PTB (200 subjects) and HIV (200 subjects). Whole blood of 7ml was collected from each participant; 4.5ml of blood was added to plain tubes for assay of cytokines, hepcidin and iron and 2.5ml for FBC, CD4 count and HIV screening. The cytokines and hepcidin were determined using Melsin ELISA Kits and Teco Diagnostics kits used for iron. Full blood count was determined by automation using Mindray BC-5300. The study revealed significant difference in IFN-γ (P=0.000), IL-6 (P=0.000) IL-10 (P=0.001), hepcidin (P=0.016), TIBC (P=0.005), %TSA (P=0.001), WBC (P=0.000), Neutrophils (P=0.000), Lymphocytes (P=0.000), Monocytes (,P=0.000), RBC (P=0.000), Haemoglobin (P=0.000), PCV (P=0.000), MCV (P=0.000), MCH (P=0.000), MCHC (P=0.000), Platelets (P=0.000), ESR (P=0.000) and no significant difference in CD4 (P=0.605), Iron (P=0.787),Eosinophils (P=0.724), Basophil (P=0.869) when compared between control and HIV subjects respectively. There were changes in the cytokines, hepcidin, TIBC, %TSA and haematological parameters studied in the subjects. There were increase in the levels of cytokines studied in patients with Pulmonary TB and HIV. The cytokines and hepcidin can be used as adjuncts to prognostic and diagnostic indicators as their levels decreased with increased duration of treatment of the patients.
- interleukin 6
- interleukin 10
- iron haematological parameters
- pulmonary tuberculosis
- human immunodeficiency virus.
How to Cite
Okonkwo RC, Anyabolu AE, Ifeanyichukwu M, Kalu SO, Onwunzo MC, Chukwuka C. Prevalence of HIV infection in pulmonary tuberculosis suspects; Assessing the Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. Advances in Life Science and Technology. 2013;14:87-90.
Divangahi M. The New Paradigm of Immunity to Tuberculosis Nature. 2013;4:294.
Yang C, Shen X., Peng Y, Lan R, Zhao Y, Long B. Transmission of mycobacterium tuberculosis in China: A population- based molecular epidemiologic study. Clinical Infectious Disease. 2015;61:219–227.
Friis H, Range N, Kristensen CB, Kæstel P, Changalucha J, Malenganisho W, Krarup H, Magnussen P, Andersen AB. Acute- phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. British Journal of Nutrition. 2009;102:310–317.
Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H, Saungweme T, Kasvosve I, Gomo ZA. and Rouault T. Association of pulmonary tuberculosis with increased dietary iron. Journal of Infectious Diseases. 184:936-939.
Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, Rouault.
Lado FL, Barriogo’mez E, Arceo EC, Carbarcosortizdebarro’n A. Clinical presentation of tuberculosis and the degree of imunodeficiency in transducer Glycoprotein 130. Journal of Immunology. 1999;164:273-282.
Ngowi BJ, Sayoki GM, Johan NB, Odd M. Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania. Bio Med Central Public Health. 2008;8:341-349.
Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends in Immunology. 2003;24:25–29.
Atreya R, Mudter J, Finotto S. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nature Medicine. 2000;6:583–588.
Armah KA, McGinnis K, Baker J. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clinical Infectious Disease. 2012;55:126–136.
Neuhaus J, Jacobs DR, Baker JV. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. Journal of Infectious Disease. 2010;201:1788–1795.
Mihret A, Abebe M. Cytokines and chemokines as biomarkers of tuberculosis. Journal of Mycobacteria Disease. 2013;3:128.
Cheesbrough M. District laboratory practice in tropical countries Part 2 (2nded.). Cambridge University Press. 2006;253-266.
Akira S, Isshiki H, Sugita T. A nuclear factor for IL-6 Expression (NF-1L6) is a Member of a C/EBP Family. European Molecular Biology Organisation Journal. 1990;9:1897-1906.
Munk ME, Emoto M. Functions of T-Cell subsets and cytokines in mycobacterial infections. European Respiratory Journal. 1995;20:668s-675s.
Deveci F, Akbulut HH, Turgut T, Muz MH. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators of Inflammation. 2005;5:256-262.
Moore KW, de Waal Malefyt R, Coff man RL, O’Garra A. Interleukin- 10 and the interleukin-10 receptor. Annual Revision of Immunology. 2001;19:683–765.
Rojas M, Olivier M, Gros P, Barrera LF, Garcia LF. TNF alpha and IL-10 modulate the induction of apoptosis by virulent mycobacterium tuberculosis in murine macrophages. Journal of Immunology. 1999;162(10):6122-6131.
Piperno A, Mariani R, Trombini P, Girella D. Hepcidin modulation in human diseases: from research to clinic. World Journal of Gastroenterology. 2009;15: 538.
Armitage AE, Eddowes LA, Gileadi U. Hepcidin regulation by innate immunity and infectious stimuli. Blood. 2011;118:4129-4139.
Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochimica et Biophysica Acta. 2012;1823:1434-1443.
Oyer RA, Schlossberg D. Hematologic changes in tuberculosis. In; 2007.
Grigoleit HG, Lehrach F, Miller R. Diabetic angiopathy and blood viscosity. Acta Diabetology. 1973;1:1311-1323.
Godfrey F, Quigley P, Ayles M, Mwinga H, Hosp A, Porter M. Screening people living with HIV before tuberculosis preventative therapy. AIDS. 1999;13: 2190-2191.
Kemya MR, Semitala FR, Quinn TC, Ronald A, Meya DN, Kizza HM, Katabira ET, Space LA. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte countamong patients with HIV disease in Kampala, Uganda. African Health Science. 2004;4:94-101.
Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K. Predictors of failure of first-line antiretroviral therapy in HIV infected adults: Indian experience. AIDS. 2007;Suppl 4:S47-S53.
Berkowitz FE. Hemolysis and infection: categories and mechanisms of their interrelationship. Review of Infectious Diseases. 1991;13(6):1151–62.
Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Review. 2002;16(2):87–96.
Means RT. Recent developments in the anemia of chronic disease. Curr ent Hematological Reports. 2003;2(2):116–121.
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation. 2004;113(9):1271.
Abstract View: 176 times
PDF Download: 145 times